← Back to Search

Culturally-Adapted Decision Support Navigation Intervention for Colorectal Cancer

N/A
Waitlist Available
Led By Sunmin Lee, ScD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female Chinese and Korean American patients aged 50 to 75, who are not up to date for colorectal cancer screening
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test whether a culturally-sensitive decision support intervention can improve colorectal cancer screening adherence among Chinese and Korean American patients.

Eligible Conditions
  • Colorectal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in colorectal cancer screening decision stage between baseline and 6 months (Colonoscopy)
Change in colorectal cancer screening decision stage between baseline and 6 months (Stool Blood Test)
Colorectal cancer screening adherence at 6 months by medical record review
+11 more
Secondary outcome measures
Change in knowledge about colorectal cancer and colorectal cancer screening between baseline and 6 months
Knowledge about colorectal cancer and colorectal cancer screening (6 months)
Knowledge about colorectal cancer and colorectal cancer screening (Baseline)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Culturally Adapted Decision Support Navigation InterventionExperimental Treatment1 Intervention
The culturally adapted decision support navigation intervention group receives everything advanced group receives as well as decision support and navigation contacts.
Group II: Advanced ControlActive Control1 Intervention
The advanced control group receives a set of standard materials regarding colorectal cancer screening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Culturally-Adapted Decision Support Navigation Intervention
2018
N/A
~400

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
542 Previous Clinical Trials
1,921,601 Total Patients Enrolled
University of Maryland, College ParkOTHER
155 Previous Clinical Trials
45,265 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
380 Previous Clinical Trials
1,215,254 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for participation in this research?

"The data housed on clinicaltrials.gov states that this research is not presently calling for volunteers, despite first being posted on August 20th 2018 and last updated June 9th 2021. However, there are 1,064 other studies actively recruiting individuals at the present moment."

Answered by AI

Could I potentially qualify for this research endeavor?

"This study is in search of 400 individuals with colorectal cancer whose ages fall between 50 and 75 years. Preference will be given to male and female Chinese and Korean American patients who are overdue for colorectal screening."

Answered by AI

Is this research initiative open to participants who are octogenarians or older?

"The age restrictions for this research requires that applicants are between 50 and 75 years old. Meanwhile, there is a total of 38 clinical trials available to those under 18 while over 1050 exist specifically tailored towards elderly patients above the age of 65."

Answered by AI
Recent research and studies
~60 spots leftby Apr 2025